Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Ladies and gentlemen, thank you for standing by. At this time, I ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Discover insights from Cytek Biosciences' Q2 2025 earnings call. Learn about revenue trends, recurring growth, new product launches, and future outlook.

The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting procedures The acquisition of 18 cell-sorting systems and associated patents positions NewGen for U.S. expa ...

The global cell analyzer market is projected to grow at a CAGR of 8% from 2025 to 2030, driven by the rising prevalence of ...

The U.S. minimal residual disease testing market is projected to soar to USD 873.66 million by 2024, driven by rising cancer rates and precision medicine. With a CAGR of 9.38% through 2033, ...

This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return ...

Flow Cytometry's growth accelerates as immuno-oncology and liquid biopsy markets expand, driving cancer research investment. Explore advancements in single-cell genomics and biotech opportunities in ...